Clinical impact of 18FDG-PET and PET/CT in the evaluation of pathologic response after treatment in oesophageal cancer's patient

被引：0
|
作者：
Gasparini, M. D. [1 ]
Florimonte, L. [1 ]
Valisi, E. [1 ]
Leo, R. [1 ]
Benti, R. [1 ]
Gerundini, P. [1 ]
机构：
[1] Fdn Osped Maggiore Policlin UO Med Nucl, Milan, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S178 / S178
页数：1
相关论文
共 50 条
  • [41] The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma
    Chowdhury, F. U.
    Bradley, K. M.
    Gleeson, F. V.
    CLINICAL RADIOLOGY, 2008, 63 (12) : 1297 - 1309
  • [42] 18FDG-PET/CT is useful in the follow-up of surgically treated patients with oesophageal adenocarcinoma
    Cuellar, Sonia L. Betancourt
    Palacio, Diana P.
    Wu, Carol C.
    Carter, Brett W.
    Correa, Arlene M.
    Hofstetter, Wayne L.
    Marom, Edith M.
    BRITISH JOURNAL OF RADIOLOGY, 2018, 91 (1082):
  • [43] Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer
    Newbold, Katie L.
    Partridge, Mike
    Cook, Gary
    Sharma, Bhupinder
    Rhys-Evans, Peter
    Harrington, Kevin J.
    Nutting, Christopher. M.
    ACTA ONCOLOGICA, 2008, 47 (07) : 1229 - 1236
  • [44] 18FDG-PET/CT IMAGING BY PERCIST PROTOCOL IN ASSESSMENT OF RESPONSE TO THE NEO-ADJUVANT CHEMOTHERAPY IN PATIENTS WITH OESOPHAGEAL CANCER AND CANCER OF GASTRO-OESOPHAGEAL JUNCTION.
    Arzykulov, Zhetkergen
    Izhanov, Ergen
    Utelbayeva, Aliya
    Abdrachmanov, Ramil
    Kim, Victor
    Chichua, Nino
    Menshikova, Irina
    Abzalbek, Estay
    ANNALS OF ONCOLOGY, 2011, 22 : v27 - v27
  • [45] 18FDG-PET/CT IMAGING BY PERCIST PROTOCOL IN ASSESSMENT OF RESPONSE TO THE NEO-ADJUVANT CHEMOTHERAPY IN PATIENTS WITH OESOPHAGEAL CANCER AND CANCER OF GASTRO-OESOPHAGEAL JUNCTION.
    Fencl, Pavel
    Harustiak, Tomas
    Zemanova, Milada
    ANNALS OF ONCOLOGY, 2011, 22 : v27 - v28
  • [46] Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma
    Dittmann, H
    Sökler, M
    Kollmannsberger, C
    Dohmen, BM
    Baumann, C
    Kopp, A
    Bares, R
    Claussen, CD
    Kanz, L
    Bokemeyer, C
    ONCOLOGY REPORTS, 2001, 8 (06) : 1393 - 1399
  • [47] Histological Grade/Differentiation and 18-FDG PET/CT in Oesophageal Cancer
    Jones, Dylan
    Al-Momani, Hazem
    Griffith, David G.
    Naguib, Nader
    Lewis, Wyn G.
    Havard, Timothy
    Escofet, Xavier
    GASTROENTEROLOGY, 2013, 144 (05) : S515 - S515
  • [48] 18FDG-PET evaluation correlates better than CT with pathological response in a metastatic colon cancer patient treated with bevacizumab-based therapy
    Funaioli, Chiara
    Pinto, Carmine
    Di Fabio, Francesca
    Santini, Donatella
    Ceccarelli, Claudio
    De Raffaele, Emilio
    Fanti, Stefano
    Castellucci, Paolo
    Longobardi, Ciro
    Buggi, Federico
    Martoni, Andrea Angelo
    TUMORI JOURNAL, 2007, 93 (06): : 611 - 615
  • [49] Current clinical use of 18FDG-PET/CT in patients with thoracic and systemic sarcoidosis
    Giuseppe Rubini
    Salvatore Cappabianca
    Corinna Altini
    Antonio Notaristefano
    Margherita Fanelli
    Amato Antonio Stabile Ianora
    Artor Niccoli Asabella
    Antonio Rotondo
    La radiologia medica, 2014, 119 : 64 - 74
  • [50] Current clinical use of 18FDG-PET/CT in patients with thoracic and systemic sarcoidosis
    Rubini, Giuseppe
    Cappabianca, Salvatore
    Altini, Corinna
    Notaristefano, Antonio
    Fanelli, Margherita
    Ianora, Amato Antonio Stabile
    Asabella, Artor Niccoli
    Rotondo, Antonio
    RADIOLOGIA MEDICA, 2014, 119 (01): : 64 - 74
12345